Back to Capital Research Global Investors Capital Research Global Investors

SNPSSNPS
7 quarters

Position history for Capital Research Global InvestorsCapital Research Global Investors's holdings in SYNOPSYS INC

Yes. Capital Research Global Investors holds 2,279,877 shares of SNPS (Synopsys), worth $1B, as of its Q2 2026 13F filing. It increased the position by 216,999 shares (+10.5%) from Q1 2026. Capital Research Global Investors has held SNPS since Q4 2024, across 7 quarterly 13F filings. SNPS is 0.1% of Capital Research Global Investors' reported 13F portfolio.

Current Value

$1B

Current Shares

2.3M

Total Value Change

+$777.1M

Total Shares Change

+1.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.3M
+10.5%
$1B0.1%$446.07
42
2026-Q1
Increased
2.1M
+8.9%
$817.8M0.1%$396.48
41
2025-Q4
Decreased
1.9M
-24.9%
$890.1M0.2%$469.72
0
2025-Q3
Increased
2.5M
+226.6%
$1.2B0.2%$493.39
62
2025-Q2
Increased
773,080
+14.7%
$396.3M0.1%$512.68
36
2025-Q1
Increased
674,261
+36.4%
$289.2M0.1%$428.85
40
2024-Q4
New
494,198
-
$239.9M0.0%$485.36
43

Other major holders of SNPS: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used